Perfil
Anders Edvell is currently Chief Executive Officer at Immedica Pharma AB since 2018, President & Chief Executive Officer at Immedica Pharma US, Inc. starting in 2025, Director at LFF Service AB, and Country Manager at Swedish Orphan Biovitrum International AB. Former positions include Chief Executive Officer at Unimedic AB, Independent Director at Rls Global AB in 2023, and VP, Head-Specialty Care & Partner Products at Swedish Orphan Biovitrum AB. Education includes an MBA and a doctorate from Stockholm School of Economics, undergraduate studies at the University of Basel, and undergraduate studies at the Scandinavian International Management Institute.
Cargos activos de Anders Edvell
| Empresas | Cargo | Inicio |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Director Ejecutivo | 11/02/2025 |
LFF Service AB | Director/Miembro de la Junta | - |
Swedish Orphan Biovitrum International AB
Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products and drugs | Corporate Officer/Principal | - |
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Director Ejecutivo | 01/08/2018 |
Antiguos cargos conocidos de Anders Edvell.
| Empresas | Cargo | Fin |
|---|---|---|
| RLS GLOBAL AB (PUBL) | Director/Miembro de la Junta | 20/11/2023 |
Unimedic AB
Unimedic AB Pharmaceuticals: MajorHealth Technology Manufactures liquid pharmaceutical drugs | Director Ejecutivo | - |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Formación de Anders Edvell.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scandinavian International Management Institute
Scandinavian International Management Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unimedic AB
Unimedic AB Pharmaceuticals: MajorHealth Technology Manufactures liquid pharmaceutical drugs | Health Technology |
LFF Service AB | |
Swedish Orphan Biovitrum International AB
Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products and drugs | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Health Technology |
RLS Global AB
RLS Global AB BiotechnologyHealth Technology Develops biochemical products | Health Technology |
- Bolsa de valores
- Insiders
- Anders Edvell
















